Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01525355 · ClinicalTrials.gov registry record
EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 34
- Enrollment target
NCT01525355: Completed study, sponsored by Wake Forest University Health Sciences.
NCT01525355 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01525355 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
Performing an EUS prior to ERCP in the setting of a positive intraoperative cholangiogram will identify and risk stratify patients for the presence of CBD stones and strictures.
Primary Outcome
Stone seen by EUS confirmed by ERCP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-06-07 |
What the finished NCT01525355 record still lists
NCT01525355 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01525355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01525355 about?
NCT01525355 is a clinical study titled "EUS Prior to ERCP in the Positive Setting of Positive Intraoperative Cholangiogram (IOC) During Cholecystectomy". Performing an EUS prior to ERCP in the setting of a positive intraoperative cholangiogram will identify and risk stratify patients for the presence of CBD stones and strictures.
What is the current status of trial NCT01525355?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2010-10. Estimated completion is 2016-06-07.
Who is sponsoring clinical trial NCT01525355?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia